Home » ImmunoGen Is Rising on Amgen News
ImmunoGen Is Rising on Amgen News
ImmunoGen Inc. announced … that Amgen Inc. licensed the exclusive right to use ImmunoGen’s maytansinoid Targeted Antibody Payload technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May